Too Expensive30 Sep 2022 01:20
I'm sorry if my earlier post sounded harsh. It was not my intention to offend or enflame. However, I am sincere in my belief that the share is underweight. My not entirely random figure of 320p was based on the 200 week MA, and a number of others things. By "poor quality earnings", I was referring to the ROCE, ROE and ROA, all of which have declined a bit since 2020. I also don't like its Debtor’s Turnover Ratio compared to others. As for being an AIM share, I note only that over 90% of its shares are already on the market, just like a grown-up, main market company. I bought a small number back in April 2020, in anticipation of the recession, kept them through some bad times and sold them in May this year , a gain of about 20%. It seemed a long wait. So, I was surprised to see it go as high as it has recently, devouring the already slim divvies on the way, but now look what happens; the company cashes in on the elevated share price.
I've got nothing against HAT, it's on my watch list and I'd buy it again if the price were right. I'm just not sure it is.